These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32750539)

  • 1. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2020 Nov; 26(11):1488-1492. PubMed ID: 32750539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2021 Feb; 27(2):288.e1-288.e4. PubMed ID: 33198949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T;
    Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Listeria monocytogenes isolates from human cases in northern Italy, 2008-2010: MIC determination according to EUCAST broth microdilution method.
    Madeo M; Musumeci R; Careddu AM; Amato E; Pontello MM; Cocuzza CE
    J Chemother; 2015 Aug; 27(4):201-6. PubMed ID: 24720267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.
    Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
    J Clin Microbiol; 2016 Dec; 54(12):2956-2962. PubMed ID: 27654337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
    Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
    Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter evaluation of broth microdilution test, BrothMIC MTB, to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for Mycobacterium tuberculosis--evaluation of interlaboratory precision and interpretive compatibility with agar proportion method].
    Yamane N; Ichiyama S; Kawahara S; Iinuma Y; Saitoh H; Shimojima M; Udagawa H; Nakasone I
    Rinsho Byori; 1999 Aug; 47(8):754-66. PubMed ID: 10511808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
    Bengtsson S; Bjelkenbrant C; Kahlmeter G
    Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
    Schön T; Köser CU; Werngren J; Viveiros M; Georghiou S; Kahlmeter G; Giske C; Maurer F; Lina G; Turnidge J; van Ingen J; Jankovic M; Goletti D; Cirillo DM; Santin M; Cambau E;
    Clin Microbiol Infect; 2020 Nov; 26(11):1453-1455. PubMed ID: 32768492
    [No Abstract]   [Full Text] [Related]  

  • 10. Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values.
    Karatuna O; Dance DAB; Matuschek E; Åhman J; Turner P; Hopkins J; Amornchai P; Wuthiekanun V; Cusack TP; Baird R; Hennessy J; Norton R; Armstrong M; Zange S; Zoeller L; Wahab T; Jacob D; Grunow R; Kahlmeter G
    Clin Microbiol Infect; 2020 Jul; ():. PubMed ID: 32653660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European multi-centre study to establish MIC and zone diameter epidemiological cut-off values for Bacillusanthracis.
    Dematheis F; Manzulli V; Grass G; Matuschek E; Jacob D; Melzer F; Elschner M; Kedrak-Jablonska A; Budniak S; Mori M; Fancello T; Grunow R; Kahlmeter G; Galante D; Zange S
    Clin Microbiol Infect; 2024 Jun; ():. PubMed ID: 38852852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utility.
    Kahlmeter G; Turnidge J
    Clin Microbiol Rev; 2023 Dec; 36(4):e0010022. PubMed ID: 38038445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.
    Maurer FP; Pohle P; Kernbach M; Sievert D; Hillemann D; Rupp J; Hombach M; Kranzer K
    Clin Microbiol Infect; 2019 Mar; 25(3):379.e1-379.e7. PubMed ID: 29906595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio species: development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints.
    Karatuna O; Matuschek E; Åhman J; Caidi H; Kahlmeter G
    J Antimicrob Chemother; 2024 Feb; 79(2):375-382. PubMed ID: 38158720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.
    Juréen P; Angeby K; Sturegård E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schön T
    J Clin Microbiol; 2010 May; 48(5):1853-8. PubMed ID: 20237102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to: ECOFFs-the why, the how, and the don'ts of EUCAST epidemiological cutoff values.
    Kahlmeter G; Turnidge J
    Clin Microbiol Infect; 2022 Jul; 28(7):952-954. PubMed ID: 35218980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-technique variability between antimicrobial susceptibility testing methods affects clinical classification of cefuroxime in strains close to breakpoint.
    Ballestero-Téllez M; Jiménez-Morgades E; Arjona-Camacho P; Blanco-Suárez A; Padilla-Esteba E; Pérez-Jové J
    Clin Microbiol Infect; 2020 May; 26(5):648.e1-648.e3. PubMed ID: 31972319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.